IHH Healthcare Bhd.

In the news

IHH Healthcare dragged down by goodwill impairment Jun 29, 2020
Bangkok virtual hospital finds opportunity in lockdown Jun 6, 2020
Singapore health tech mClinica to raise $20m as coronavirus spurs growth May 1, 2020
Asian stocks rebound as central banks pledge support to fight virus impact Mar 2, 2020
Asia businesses brace for virus amid China New Year exodus Jan 22, 2020

See more articles on IHH Healthcare Bhd.

Company Background

IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.

Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.

IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.

IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.

Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.

Business Summary

IHH Healthcare Bhd. is an investment holding company, which engages in the provision of healthcare services. It operates through the following segments: Singapore, Malaysia, India, Greater China, PPL Others Acibadem Holdings CEE, IMU Health Malaysia, PLife REIT, and Others. The company was founded on May 21, 2010 and is headquartered in Kuala Lumpur, Malaysia.

Financial Highlights

Dec 2021	MYR	USD
Revenue	17,131.76M	4,132.87M
Gross Profit	4,597.75M	1,109.16M
Operating income	2,434.29M	587.25M
Income before tax	2,515.88M	606.93M
Net income	1,774.22M	428.01M
EBITDA	3,749.18M	904.45M
Diluted EPS	0.20	0.04
Dividends Per Share	0.06	0.01
Total Assets	45,510.26M	10,924.21M
Total liabilities	20,391.79M	4,894.81M
Total equity	22,424.93M	5,382.84M
Operating cash flow	3,225.22M	778.05M
	Currency in MYR	Currency in USD

Historical Data

MYR | USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021
Revenue	11,142.63M	11,520.93M	14,912.48M	13,404.60M	17,131.76M
Gross Profit	2,620.19M	2,884.52M	3,677.11M	2,709.70M	4,597.75M
Operating income	1,068.88M	1,203.24M	1,685.73M	914.38M	2,434.29M
Income before tax	1,162.33M	739.05M	968.61M	549.11M	2,515.88M
Net income	931.31M	541.84M	463.30M	199.03M	1,774.22M
EBITDA	2,046.96M	2,142.40M	3,041.22M	2,311.70M	3,749.18M
Diluted EPS	0.11	0.06	0.05	0.02	0.20
Dividends Per Share	0.03	0.03	0.04	0.04	0.06
Total Assets	38,925.48M	45,020.85M	45,111.62M	44,746.72M	45,510.26M
Total liabilities	15,183.41M	18,827.09M	19,175.82M	19,869.41M	20,391.79M
Total equity	21,890.16M	21,994.00M	22,339.53M	21,739.81M	22,424.93M
Operating cash flow	2,006.03M	1,562.71M	2,595.44M	2,085.16M	3,225.22M

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021
Revenue	2,591.60M	2,854.98M	3,599.45M	3,189.89M	4,132.87M
Gross Profit	609.41M	714.80M	887.55M	644.82M	1,109.16M
Operating income	248.60M	298.17M	406.88M	217.59M	587.25M
Income before tax	270.34M	183.14M	233.79M	130.67M	606.93M
Net income	216.60M	134.27M	111.82M	47.36M	428.01M
EBITDA	476.09M	530.90M	734.06M	550.11M	904.45M
Diluted EPS	0.02	0.01	0.01	0.00	0.04
Dividends Per Share	0.00	0.00	0.00	0.00	0.01
Total Assets	9,618.35M	10,894.33M	11,028.38M	11,124.10M	10,924.21M
Total liabilities	3,751.77M	4,555.86M	4,687.89M	4,939.56M	4,894.81M
Total equity	5,408.98M	5,322.20M	5,461.32M	5,404.55M	5,382.84M
Operating cash flow	466.57M	387.25M	626.46M	496.20M	778.05M

Valuation Measures

Dec 2021
PER	36.33
ROA	3.93%
ROE	8.03%
Operating margin	14.20%
Profit margin	10.35%

Key executives

CEO, MD & Non-Independent Executive Director: Chi Keon Loh
Group Chief Operating Officer: Heng Joo Sim
Group Chief Financial Officer: Joerg Ayrle
Group Chief Strategy Officer: Ashok Pandit
Group Head-Internal Audit: Stephen Byrne

Shareholders

Mitsui & Co., Ltd. (32.8%)
Khazanah Nasional Bhd. (Investment Company) (25.9%)
Employees Provident Fund (9.7%)
Permodalan Nasional Bhd. (4.8%)
AYDINLAR MEHMET ALI (4.8%)
Kumpulan Wang Persaraan (3.2%)
Kuwait Investment Authority (Investment Management) (1.7%)
Public Mutual Bhd. (1.2%)
AYDINLAR FAMILY (1.1%)
The Vanguard Group, Inc. (0.9%)

Contact Details

Website:http://www.ihhhealthcare.com
Address: Pantai Hospital Kuala Lumpur, 8 Jalan Bukit Pantai, Kuala Lumpur, 59100, Malaysia
Phone: +60.3.2298.9898

Related Companies

IHH Healthcare Bhd. (Singapore)
Centre For Digestive & Kidney Diseases India Pvt Ltd.
Indah Capital Ltd.
Shanghai Mai Kang Hospital Investment Management Co. Ltd.
Bodrum Tedavi Hizmetleri A.S
Integrated Healthcare Turkey Yatirimlari Ltd.
Integrated Healthcare Holdings (Bharat) Ltd.
Integrated Healthcare Holdings Ltd.
Acibadem Saglik Hizmetleri ve Ticaret AS
Pantai Holdings Sdn. Bhd.
Parkway Holdings Ltd.

Competitors

Last Updated on 24 Jun, 2022